
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny is a leading fertility benefits platform with strong growth potential, supported by favorable demographics, partnerships, and a unique model. The company has shown strong clinical outcomes and retention, driving strong growth in the fully insured employer market. With a focus on adding 1 million new covered lives annually, efficient management and strong financials make Progyny a promising investment opportunity for the long-term.
Bears say
Progyny is a benefits management company that specializes in fertility, family building, and women's health benefits solutions. While the company has maintained a strong client retention rate and has won a significant share of competitive decisions, its market share gains may not be sustainable in the long term as the market matures and more competitors enter. Additionally, Progyny's expansion into the insurance market introduces a different risk profile and may impact profitability. It remains to be seen if the pharmacy benefit management platform and other modernization initiatives will result in increased profitability for the company.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares